Danny Glover ‘Acting’ as Spokesman for Anemia LifeLine

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 5
Volume 11
Issue 5

NEW YORK-Actor Danny Glover is serving as spokesman for Anemia LifeLine, a new educational initiative. Mr. Glover’s father had anemia associated with chronic kidney disease. At a press conference to launch the initiative, Mr. Glover told how anemia had robbed his father James Glover of his desire to do the things he loved. He said his father was ready to give up, but treatment gave him back his energy and independence.

NEW YORK—Actor Danny Glover is serving as spokesman for Anemia LifeLine, a new educational initiative. Mr. Glover’s father had anemia associated with chronic kidney disease. At a press conference to launch the initiative, Mr. Glover told how anemia had robbed his father James Glover of his desire to do the things he loved. He said his father was ready to give up, but treatment gave him back his energy and independence.

Anemia LifeLine was developed by Amgen Inc. in collaboration with the National Kidney Foundation; The Wellness Community, a national support group for cancer patients; and the National Anemia Action Council, representing various clinical specialties.

The campaign was designed to increase awareness of the signs and symptoms of anemia associated with serious disease, provide educational materials, encourage people to seek treatment, and demonstrate that treatment can lead to a healthier, more productive life.

Mr. Glover will make appearances throughout the country at National Kidney Foundation Kidney Walks and at anemia awareness events at malls. He will be featured in public service announcements and in educational materials available via a toll-free line (1-888-722-4407) and on the web (www.anemia.com). 

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content